A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents
Dietmar Trenk(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Franz‐Josef Neumann(University of Freiburg), Ulrike Müller(Deutsches Herzzentrum der Charité), Gregg W. Stone(Cardiovascular Institute of the South), Meinrad Gawaz(University of Tübingen), Gert Richardt(Badr University in Cairo), Adnan Kastrati(Deutsches Herzzentrum München), Joseph A. Jakubowski(Indiana Biosciences Research Institute), Dominick J. Angiolillo(University of Florida)
Cited by 617
Related Papers
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
|New England Journal of Medicine|2012|2.8k
Bivalirudin for Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2006|1.5k